RISPOLEPT CONSTA
Powder and solvent for prolonged-release suspension for injection, 25mg
RxActive license
Active substance (INN)
risperidone
Pharmaceutical form
Pharmaceutical formPowder and solvent for prolonged-release suspension for injection
Strength25mg
PackagingUkupno 1 bočica staklena sa praškom za suspenziju za injekciju i 1 napunjeni injekcioni špric sa 2ml rastvarača u kartonskoj kutiji
ManufacturerCilag AG, Switzerland
Therapeutic groupNervous system (N05AX08)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateNovember 18, 2024
Analogs in Montenegro
8Other medicines with the same active substance
RISPOLEPT CONSTARx
Powder and solvent for prolonged-release suspension for injection, 50mgRISPOLEPT CONSTARx
Powder and solvent for prolonged-release suspension for injection, 37.5mgRISSARRx
Film-coated tablet, 2mgRISSARRx
Film-coated tablet, 3mgRISSARRx
Film-coated tablet, 1mgTORENDORx
Film-coated tablet, 1mgTORENDORx
Film-coated tablet, 2mgTORENDORx
Film-coated tablet, 3mgSource: CInMED register